Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.11% Nasdaq Down0.42%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
12.13 Down 0.19(1.53%) 9:53AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development1,395  1,192  1,349  1,752  
Selling General and Administrative1,409  2,353  1,198  1,456  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,804) (3,545) (2,547) (3,208)
Income from Continuing Operations
Total Other Income/Expenses Net5  3  3  5  
Earnings Before Interest And Taxes(2,799)(3,542)(2,544)(3,203)
Interest Expense -   -   -   -  
Income Before Tax(2,799)(3,542)(2,544)(3,203)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,799)(3,542)(2,544)(3,203)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,799) (3,542) (2,544) (3,203)
Preferred Stock And Other Adjustments(312)(181)(9,097)(269)
Net Income Applicable To Common Shares (3,111) (3,723) (11,641) (3,472)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.